Skip to main content

Blum Robert I's Form 4 filing

Cytokinetics Inc (CYTK) · filed Aug 28, 2023

Accession no.
0001127602-23-023304
Filed
Aug 28, 2023
Trade date
Aug 25, 2023
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $424.9K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blum Robert ICIK 0001288859Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 25, 2023Common StockMOption exerciseAcquired+2,500$6.67+$16,675443,917Direct
Aug 25, 2023Common StockMOption exerciseAcquired+10,000$7.96+$79,600453,917Direct
Aug 25, 2023Common StockSSaleDisposed−12,500$33.99−$424,875441,417Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 25, 2023Common StockMOption exerciseDisposed−2,500$0.00$0255,994Direct
Aug 25, 2023Common StockMOption exerciseDisposed−10,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)